Under-the-Tongue Allergy Therapy Cost-Effective

According to a recent report, under-the-tongue or "sublingual" immunotherapy (SLIT) is cost-effective for treating adults with pollen-induced respiratory allergy. It is being widely used in many countries e.g. Italy, Germany, France, Spain, Portugal, Greece, and Hungary.

The report also added that SLIT improved symptoms of 63 percent of patients and prevented asthma in 52 percent of patients, compared with 23 percent and 29 percent, respectively, of patients receiving standard treatment.
However, SLIT is not officially in use in the United States as clinical studies endorsed by the FDA are still currently ongoing to get the approval.